Beihai Gofar Chuanshan Biological Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 192.97 million compared to CNY 217.98 million a year ago. Revenue was CNY 194.25 million compared to CNY 219.26 million a year ago.

Net loss was CNY 9.75 million compared to net income of CNY 8.72 million a year ago. Basic loss per share from continuing operations was CNY 0.02 compared to basic earnings per share from continuing operations of CNY 0.02 a year ago. Diluted loss per share from continuing operations was CNY 0.02 compared to diluted earnings per share from continuing operations of CNY 0.02 a year ago.